-
EntrepreneurRICOVR Rapid Saliva Testing For Biomarkers
-
EntrepreneurWibly Visual Learning Platform for Knowledge Networks
-
EntrepreneurSovány Beverage Sovany is more than just another organic sparkling water
-
EntrepreneurSimple Ideas PureE Disruptive IP Broad Spectrum Oral Anti-Pathogen Pharmaceutical
-
EntrepreneurCommerceBlitz
-
EntrepreneurSmall Eyes
-
EntrepreneurTAM-C Solutions
-
EntrepreneurPascal Metrics
-
EntrepreneurIM Financial We are a technology platform focused on providing lifestyle embedded financial services for the hispannial-americans building their American dream.
-
Information
iCFO Information Booth How can we help? -
Entrepreneur
Arise BioPharma -
Entrepreneur
Oberit
Event DealConnect 360: The Ultimate Deal Room for Real Results! is over.
Join us next time to meet Gordon Bethwaite!
Join us next time to meet Gordon Bethwaite!
About Vitranu
Vitranu
A drug delivery company developing a Tunable Extended-Release CapsuleTM (TERCTM) capable of long-term delivery of therapeutics via injection
Available from
1:30 PM
-
4:00 PM
(US/Pacific)
404 697 4853
Age-related macular degeneration and other retinal diseases cause debilitating loss of vision, and the standard of care treatment is an injection of therapeutics directly into the eye as often as every month. This injection frequency creates a huge burden on the healthcare system, and most importantly on patients and their caregivers. Vitranu is developing the Tunable Extended-Release Capsule or TERC, a sustained-release drug delivery technology designed to significantly reduce the frequency of eye injections, with the goal of six months or more of treatment in a single injection. By providing an extended duration of treatment, Vitranu aims to increase compliance and ultimately preserve the most precious gift of sight for more patients.
